
Viridian Therapeutics, Inc.
USD19.18
+0.62 (+3.34%)
CEO
Stephen F. Mahoney
IPO Date
2014-06-18
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$18.55
Prev. Close
$18.56
Day Low
$18.48
Day High
$19.27
52W Low
$13.18
52W High
$34.29
Market Cap
$1.73B
Volume
1.09M
| 30 Jun 2026 |
| RBC Capital |
| Outperform |
| Outperform |
| maintain |
| 29 Jun 2026 | Wells Fargo | Equal Weight | Overweight | upgrade |
| 29 Jun 2026 | Needham | Buy | Buy | maintain |
| 15 May 2026 | Evercore ISI Group | Outperform | Outperform | maintain |
| 6 May 2026 | RBC Capital | Outperform | Outperform | maintain |
| 5 May 2026 | Needham | Buy | Buy | maintain |
| 21 Apr 2026 | Truist Securities | Buy | Buy | maintain |